 |
인쇄하기
취소
|
Local drug makers boosting R&D spending
Listed pharmaceutical firms have been spending more on research and development (R&D) projects to meet standards for the government support.
The Financial Supervisory Service (FSS) said Monday that the combined R&D spending by Korea's 53 listed companies came to 162.8 billion won during the first three months of this year, up 1.7 percent from a year earlier.
This figure shows these compan...
The Financial Supervisory Service (FSS) said Monday that the combined R&D spending by Korea's 53 listed companies came to 162.8 billion won during the first three months of this year, up 1.7 percent from a year earlier.
This figure shows these compan...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.